Abstract:Background The head-twitch response (HTR) in mice is considered a behavioral model for hallucinogens and serotonin 5-HT 2A receptor function, as well as Tourette syndrome in humans. It is mediated by 5-HT 2A receptor agonists such as ( ±)− 2,5-dimethoxy-4-iodoamphetamine (DOI) in the prefrontal cortex (PFC). The 5-HT 2A antagonist EMD 281014, can prevent both DOI-induced HTR during ageing and c-fos expression in different regions of PFC. Moreover, the nonselective monoamine releaser methamphetamine (MA) suppressed DOI-induced HTR through ageing via concomitant activation of inhibitory 5-HT 1A receptors, but enhanced DOI-evoked c-fos expression. d -Fenfluramine is a selective 5-HT releaser and induces HTR in mice, whereas MA does not. Currently, we investigated whether EMD 281014 or MA would alter: (1) d -fenfluramine-induced HTR frequency in 20-, 30- and 60-day old mice, (2) d -fenfluramine-evoked c- fos expression in PFC, and (3) whether blockade of inhibitory serotonergic 5-HT 1A - or adrenergic ɑ 2 -receptors would prevent suppressive effect of MA on d -fenfluramine-induced HTR. Results EMD 281014 (0.001–0.05 mg/kg) or MA (0.1–5 mg/kg) blocked d -fenfluramine-induced HTR dose-dependently during ageing. The 5-HT 1A antagonist WAY 100635 countered the inhibitory effect of MA on d -fenfluramine-induced HTR in 30-day old mice, whereas the adrenergic ɑ 2 antagonist RS 79948 reversed MA’s inhibitory effect in both 20- and 30- day old mice. d -Fenfluramine significantly increased c- fos expressions in PFC regions. MA (1 mg/kg) pretreatment significantly increased d -fenfluramine-evoked c- fos expression in different regions of PFC. EMD 281014 (0.05 mg/kg) failed to prevent d -fenfluramine-induced c- fos expression, but significantly increased it in one PFC region (PrL at − 2.68 mm). Conclusion EMD 281014 suppressed d -fenfluramine-induced HTR but failed to prevent d -fenfluramine-evoked c- fos expression which suggest involvement of additional serotonergic receptors in the mediation of evoked c- fos . The suppressive effect of MA on d -fenfluramine-evoked HTR is due to well-recognized functional interactions between stimulatory 5-HT 2A - and the inhibitory 5-HT 1A - and ɑ 2 -receptors. MA-evoked increases in c- fos expression in PFC regions are due to the activation of diverse monoaminergic receptors through increased synaptic concentrations of 5-HT, NE and/or DA, which may also account for the additive effect of MA on d -fenfluramine-evoked changes in c- fos expression. Our findings suggest potential drug receptor functional interaction during development when used in combination.

Effects of fentanyl and the adulterant levamisole on the rewarding and locomotor effects of methamphetamine in rats

Fentanyl self‐administration is accelerated by methamphetamine co‐use and results in worsened hypodopaminergia in male, but not female rats

Methamphetamine and the Synthetic Cathinone 3,4-Methylenedioxypyrovalerone (MDPV) Produce Persistent Effects on Prefrontal and Striatal Microglial Morphology and Neuroimmune Signaling following Repeated Binge-like Intake in Male and Female Rats

Effectiveness Comparisons of G-protein Biased and Unbiased Mu Opioid Receptor Ligands in Warm Water Tail-Withdrawal and Drug Discrimination in Male and Female Rats

Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys

Psilocin Suppresses Methamphetamine‐induced Hyperlocomotion and Acquisition of Conditioned Place Preference Via D2R‐mediated ERK Signaling

Extinction-Dependent Alterations in Corticostriatal mGluR2/3 and mGluR7 Receptors following Chronic Methamphetamine Self-Administration in Rats

The effects of chronic neuropathic pain states on the discriminative stimulus effect of fentanyl and other MOR agonists

Two Inbred Strains of Rats, Fischer 344 and Lewis, Showed Differential Behavior and Brain Expression of Corticosterone Receptor mRNA Induced by Methamphetamine

Neurotoxic Methamphetamine Doses Alter CDCel-1 Levels and Its Interaction with Vesicular Monoamine Transporter-2 in Rat Striatum

Self-Administration of Fentanyl-Alprazolam Combinations by Rhesus Monkeys Responding under a Progressive-Ratio Schedule

The Distinct Roles of Various Neurotransmitters in Modulating Methamphetamine-Induced Conditioned Place Preference in Relevant Brain Regions in Mice

Xylazine does not enhance fentanyl reinforcement in rats: a behavioral economic analysis

Behavioral Sensitization Induced by Methamphetamine Causes Differential Alterations in Gene Expression and Histone Acetylation of the Prefrontal Cortex in Rats

Effects of Low-Doses of Methamphetamine on D-Fenfluramine-induced Head-Twitch Response (HTR) in Mice During Ageing and C-Fos Expression in the Prefrontal Cortex

Novel synthetic opioids produce potent morphine‐like discriminative stimulus effects in rats

mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats

The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in mice.

Reinforcing and Discriminative-Stimulus Effects of Two Pyrrolidine-Containing Synthetic Cathinone Derivatives in Rats.

Effects of Fentanyl Dose and Exposure Duration on the Affective and Somatic Signs of Fentanyl Withdrawal in Rats.